Gambro Prismaflex
This article was originally published in The Gray Sheet
Executive Summary
Firm announces European launch of a renal failure treatment system to update its Prisma. The device is set to be launched in the U.S. by year-end and allows for continuous renal replacement therapy, Gambro says. When compared to the earlier Prisma, Prismaflex offers a bar code reader, higher flow rates and a new bag handling system for greater ease of use, according to the Swedish firm, which controls of 55% of the worldwide renal care market...